Brief: AcelRx Pharmaceuticals Reports Fourth Quarter And Full Year 2021 Financial Results
10/03/2022 21:12
March 10 (Reuters) - AcelRx Pharmaceuticals Inc ACRX.O :
* ACELRX PHARMACEUTICALS REPORTS FOURTH QUARTER AND FULL
YEAR 2021
FINANCIAL RESULTS
* Q4 LOSS PER SHARE $0.06
Source text for Eikon: ID:nPn1vj9z8a
Further company coverage: ACRX.O
Recent news on Talphera
See all newsTalphera Inc reports results for the quarter ended June 30 - Earnings Summary
Talphera Inc expected to post a loss of 7 cents a share - Earnings Preview
Talphera Q1 net loss narrows as costs rise on higher development spending
Talphera Q4 net loss widens as operating expenses rise
Brief: Talphera Announces 50% Enrollment Milestone In Ongoing Nephro-Crrt Registrational Trial